rapid-acting antidepressants

rapid-acting antidepressants

Remarkable Results in a Preliminary Clinical Test of a Rapid-Acting Antidepressant Treatment
Imagine a new treatment for people with major depression who have not responded to existing treatments—one that acts rapidly and... Read More
In a Surprising Clinical Trial, Ketamine’s Antidepressant Effects Lasted Longer
Carefully designed, exquisitely controlled experiments sometimes don't produce the result predicted in advance—the research “hypothesis” that is the starting point... Read More
Over Two Decades, 90 BBRF Grants Helped Build a Scientific Foundation for the First Rapid-Acting Antidepressants
In the spring of 2019, The Food and Drug Administration granted approval for two breakthrough medicines that act rapidly to... Read More
Study: Ketamine Restores Neural Connection Points Lost in Stress & Depression
Researchers led by 2013 BBRF Young Investigator Conor Liston, M.D., Ph.D. , have just reported a surprising finding about the... Read More
Advisory Panel Recommends FDA Approval of Esketamine , with New Mechanism to Treat Resistant Depression & Suicidal Thinking
On February 12th, an FDA advisory panel recommended overwhelmingly that the agency approve a drug called esketamine for the rapid... Read More